Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Policy / Pricing

Medicare obesity drug pilot extended after insurer pushback

 April 22, 2026

Pharmaphorum

Medicare will cover the cost of a pilot of weight-loss drug coverage, after health insurers refuse to take part.

Policy / PricingMetabolic & GLP-1Read full story

Post navigation

Health Canada approves Biocon’s two denosumab biosimilars →
← BioAegis and Prenosis partner for inflammatory disease therapies

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com